Jim Deal Appointed to MedCath's Board of Directors
August 10 2009 - 7:30AM
PR Newswire (US)
CHARLOTTE, N.C., Aug. 10 /PRNewswire-FirstCall/ -- MedCath
Corporation (NASDAQ:MDTH), a healthcare provider focused on high
acuity healthcare services, predominately the diagnosis and
treatment of cardiovascular disease, today announced that James
"Jim" Deal has been appointed to its board of directors. Deal is an
accomplished health care services CEO. Some of his career
highlights: -- Since 2006, he's led Hospice Compassus of Brentwood,
Tenn., co-founding a company that's become a leading hospice
services provider, serving about 2,700 patients daily at 53
locations in 15 states. -- From 2002 to 2006, he served as chairman
and CEO of INSPIRIS in Nashville, Tenn., which manages the health
care of the frail elderly. Deal transformed the business model of
the company and made it profitable. -- He served as president and
CEO of the Center for Diagnostic Imaging in Minneapolis for three
years, expanding same store growth and using existing cash flow to
triple the number of locations. -- He spent 15 years as president
of Diabetes Treatment Centers of America, helping grow the company
into one of the nation's leading providers of disease and care
management services in the country. -- He's served as a CEO or
executive at several hospitals nationwide. Deal has also been on
the board of directors for AmSurg Corp. in Nashville since 1992,
chairing the audit committee since 1999, and he previously spent
three years on the board of the Pediatric Nursing Services of
America. He earned a master's of Public Administration in Health
Services Administration from the University of Arizona, and a
bachelor's of business in economics from Western Illinois
University. "Jim has a proven record of being able to help
companies grow, and I'm excited that he will bring that insight to
our board of directors," said Board Chairman John Casey. "He
possesses strategic skills, leadership traits and a wealth of
operational, financial, and corporate development experience that
will be a tremendous benefit." Executive search firm Caldwell
Partners assisted MedCath's Governance and Nominating Committee
with the selection. MedCath Corporation, headquartered in
Charlotte, N.C., is a healthcare provider focused on high acuity
services with the diagnosis and treatment of cardiovascular disease
being a primary service offering. MedCath owns an interest in and
operates nine hospitals with a total of 755 licensed beds, located
in Arizona, Arkansas, California, Louisiana, New Mexico, South
Dakota, and Texas. MedCath is in the process of developing its
tenth hospital, which is anticipated to open in fall 2009, in
Kingman, Ariz. In addition, MedCath and its subsidiary MedCath
Partners provide services in diagnostic and therapeutic facilities
in various states. DATASOURCE: MedCath Corporation CONTACT: O.
Edwin French, President & Chief Executive Officer, or Art
Parker, Interim Chief Financial Officer, both of MedCath
Corporation, +1-704-708-6600 Web Site: http://www.medcath.com/
Copyright
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024